Vial label design and print may vary between batches. Product specifications remain unchanged.
At a glance
Strength
10mg per vial
Form
Lyophilised powder
Purity
≥ 99% (HPLC)
CAS number
62568-57-4
Molecular weight
848.81 g/mol
Certificate of Analysis
Batch DS-10-10 · Prime Peptides UK
Neuroactive & cognitive
DSIP
Synthetic research peptide · 10mg · CAS 62568-57-4
£24.95 In stock · ready to shipper vial · £2.50 per mg
DSIP 10mg is coming soon. It goes on sale as soon as its batch certificate is published - every vial we sell has a matching CoA.
Bank transferBitcoin Encrypted checkout · card details are never taken on this site
Multi-item discount. Add any 2 items for 4% off the whole order, 7% at 3, 10% at 4. Applied automatically at checkout.
Free
Free lab add-on. Bacteriostatic water is included with every peptide order at no extra cost.
Lab essentials tap to add to this order
RUOResearch Use Only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and accept responsibility for safe, lawful handling.
Same-day dispatch
Orders before 3:00 PM leave the same working day, tracked, in plain packaging. Free UK delivery over £200.
Secure payment
Bank transfer or Bitcoin over an encrypted checkout. No card details are stored or handled on this site.
Batch tested
Every batch is HPLC and mass spectrometry tested, and its certificate is published before it ships.
DSIP 10mg≥99% HPLC · In stock
£24.95
Compound Overview
What Is DSIP 10mg?
Delta Sleep-Inducing Peptide (DSIP) is a short peptide that, in the past, has been the subject of experimental research on sleep and related processes, such as circadian rhythms and neuroendocrine functions. The 10mg presentation specifies the amount of research material provided and is only for controlled laboratory or scientific studies. DSIP is still an experimental research drug not a proven therapeutic and there are still unanswered questions about its naturally occurring function.
The nonapeptide, Delta Sleep-Inducing Peptide (DSIP), is a 9-amino-acid peptide. It has the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). According to PubChem the molecular formula is C35H48N10O15 and the molecular weight is around 848.8 g/mol.
Scientific interest was drawn to DSIP due to research on substances that might be related to sleep regulation. The presence of DSIP-like material in the history literature in various biological sites stimulated studies of sleep, circadian activity, neurotransmission, and endocrine processes. But the biological explanation of these results has been unclear.
The specified 10mg for DSIP is only for the amount of peptide research material in product format. It is not a suggested dose or indication of a correct quantity of administration.
The format is thus applicable to researchers who need a specified amount of DSIP for experimental design, analysis or lab studies carried out using known procedures.
Technical Data
DSIP Product Specifications
Technical Specification Sheet
DSIP · 10MG · RUO
Product Name
DSIP 10mg
Compound
Delta Sleep-Inducing Peptide
Alternative Name
Emideltide
Peptide Type
Nonapeptide
Strength
10mg research material
Sequence
WAGGDASGE
Molecular Formula
C35H48N10O15
Molecular Weight
Approx. 848.8 g/mol
Format
Lyophilised research material
Classification
Experimental research peptide
Documentation
Batch-specific Certificate of Analysis with every batch
Intended Use
Laboratory and scientific research only
CAS Number
62568-57-4
Purity
≥99% by HPLC
The chemical identity, sequence and molecular characteristics above are consistent with the established DSIP entry in PubChem. Product-specific analytical documentation should always be consulted for information relating to an individual supplied batch.
The Science
Scientific Background of Delta Sleep-Inducing Peptide
In the 1970's, when DSIP was isolated from rabbit cerebral venous blood, it came under the microscope of experimental investigation. Initial studies were linked with alterations in sleep-related activity, which led to its descriptive name. Research then broadened to include electrophysiological activity, neurotransmitter levels, circadian activity and hormonal processes.
All such observations should be taken in their historical and experimental context. The role of DSIP as an endogenously produced regulator of sleep has not emerged as a simple, well-defined mechanism. The scientific study that followed later stated that its link to sleep was poorly documented and pointed out some questions regarding its natural occurrence, biological activity and possible receptor or related signalling system.
This uncertainty is one of the reasons that DSIP is scientifically interesting. It is not a compound of a known mechanism, but rather offers the researchers a peptide to test several hypotheses of physiologic regulation.
Most of the literature tends to be historical, experimental or preclinical. The results of these models should therefore not be seen as clinically proven effects in humans.
Laboratory Focus
Why Does DSIP Remain a Research Subject?
DSIP interests the scientific community in a number of experimental biology fields. Initial studies examined the effect of the peptide on sleep architecture and electrophysiology under specific experimental conditions. Other studies explored possible associations to circadian rhythmicity, locomotor behavior, neurotransmitter levels and neuroendocrine mechanisms.
Sleep Regulation
Physiological variables other than sleep have also been investigated. The results of the experiments were reviewed and discussed with the changes taking place with regard to thermoregulation, cardiovascular changes, and other processes involved in the sleep transition.
Sleep Regulation
Important: These observations are not intended to imply that DSIP is a sleep aid or a therapy for any illness.
Sleep Regulation
There are also conflicting and species-specific data in the literature. In 2006 a review cast doubt on the validity of the original sleep-factor hypothesis and pointed to significant gaps in the knowledge of DSIP biology.
Laboratory Research
Consequently, DSIP is better regarded as an investigational peptide used to explore biological questions rather than as a compound with proven therapeutic properties.
Product Format
What the 10mg Research Format Represents
10mg
Nominal Research Quantity
The DSIP 10mg designation describes the nominal quantity of peptide material supplied in the research vial. This distinction matters because strength labels on laboratory compounds can otherwise be mistaken for dosing recommendations.
A 10mg research format may be selected where a laboratory's planned programme requires that quantity of material. Requirements can differ considerably according to the number of experiments, assay design, analytical procedures, controls, replication strategy and overall scale of a project.
For example, a laboratory conducting several analytical investigations may have different material requirements from a group undertaking a small preliminary study. The strength therefore provides researchers with a straightforward way to identify the amount supplied when planning procurement and experimental resources.
It does not establish how much DSIP should be administered to a person or animal, nor does the 10mg format imply greater effectiveness or suitability than another quantity. Experimental use must be determined by qualified researchers under an appropriate laboratory protocol.
Verification
Quality Testing, Identity and Certificate of Analysis
Analytical documentation is particularly important when sourcing peptides for laboratory work. Researchers need confidence that the material being evaluated corresponds with the compound identified on the product label.
Batch-Specific CoA
A Certificate of Analysis (COA) can provide useful batch-level information, including product identity, batch reference and reported analytical results. Where High-Performance Liquid Chromatography (HPLC) is used, chromatographic data may help characterise sample purity. Other analytical methods may be employed to investigate molecular identity or related quality parameters.
Documentation & Transparency
Researchers considering DSIP 10mg should check whether documentation relates specifically to the batch being supplied rather than relying solely on generic product specifications.
Batch-Specific CoA
Batch traceability also enables laboratories to connect experimental records with the material used in a particular investigation. This becomes particularly useful where experiments are repeated or results from different batches are compared.
Testing terminology should be interpreted carefully: a reported purity result describes an analytical measurement and does not establish therapeutic suitability, clinical efficacy or approval for human use.
Handling
Storage and Laboratory Handling of DSIP 10mg
Labelling & Traceability
Handling of research peptides should be carried out so as to maintain the integrity of the peptides for subsequent analytical or experimental use. The product should be stored in the original clearly labelled container and stored under the conditions of storage as described by the supplier and accompanying product documentation.
Environmental Conditions
Environmental factors, such as temperature, moisture and exposure to light, should be taken into account in the management of peptide research materials in a laboratory. If the supplier's documentation calls for controlled storage, repeated unnecessary changes in the environment should be avoided.
Contamination Control
Good laboratory practice also requires that the risk of contamination is minimised and that the batches are clearly identified throughout the storage and experimental manipulation of the material.
Reconstitution Practice
Researchers should adhere to their institution's standard operating procedures and any storage directions provided with the material for that particular batch of material. This information is for preservation of laboratory research material only and does not provide preparation or administration information.
When assessing DSIP 10mg UK suppliers, researchers must go beyond the name of the product or the number of vials. The transparency of the specification and the availability of analytical documentation are all part of responsible procurement that can be clarified.
Group specific data is particularly important as it allows laboratories to record which material was used in an experiment. Researchers may also wish to assess packaging, batch numbering, COA availability, storage information and the supplier's research-only policies.
Domestic dispatch can also make it easier for UK research organisations to plan the procurement and delivery of the materials. Commercial availability does not affect the experimental nature of DSIP.
Therefore, for those looking for a product to be used effectively, scientifically, and legally, it is advisable to consider the quality and transparency of the research documentation provided with the product, instead of assuming that the product is an established medicine or a health supplement for the consumers.
Analytical Records
Batch certificates for DSIP
Every order ships with the CoA matched to its batch number, and the analytical records
are published here - open the certificate before you order, or cross-check the one in
your parcel.
DSIP 10mg identifies a research product containing a nominal 10mg quantity of Delta Sleep-Inducing Peptide. DSIP is a nine-amino-acid peptide with the sequence WAGGDASGE. The 10mg figure describes the quantity of research material supplied; it is not a recommended dose for humans or animals.
Is DSIP 10mg a medicine for improving sleep?
No. Despite its historical name and experimental association with sleep-related research, DSIP should not be presented as an established sleep medicine. Different scientific reviews have highlighted uncertainties surrounding its natural function, mechanism and relationship with sleep. DSIP 10mg offered as a research peptide is intended solely for laboratory investigation.
Why do laboratories research DSIP?
DSIP has attracted interest because experimental literature has investigated its relationship with sleep physiology, electrophysiological activity, circadian rhythms, neurotransmitter systems and neuroendocrine processes. Results have varied between models, and several aspects of DSIP biology remain unresolved. These uncertainties make it an investigational research subject rather than evidence of established medical benefits.
Why choose a 10mg DSIP research format?
The amount of research material required by a laboratory will depend on the experimental design, the number of assays scheduled, analytical requirements and study size. The 10mg format is just a fixed amount for research planning purposes. It is not a suggested experimental dose and should never be used as a suggestion for human ingestion or self-administration.
What information should be checked on a DSIP COA?
Researchers should look for clear product identification, batch or lot information and the analytical results reported for that particular sample. Where appropriate, paperwork may incorporate chromatographic purity information or other identity-related analytical data. The COA should ideally be traceable to the batch supplied so experimental records can be linked accurately to the research material used.
Is DSIP research considered conclusive?
No. DSIP has many experimental years at its disposal, there are still a number of important scientific questions that are yet to be answered. Various sleep-related and physiological observations were reported in early studies, but later reviews focused on the lack of clarity of its endogenous role and mechanism. It is therefore important to differentiate historical or preclinical observations from clinical evidence.
PG
Medically & Scientifically Reviewed By
Dr. Priyanka Goel
Scientific & Medical Content Reviewer
Reviews research content against current published literature and UK regulatory guidance, ensuring compound information is accurate, referenced and presented for research use only.
DSIP 10mg is only supplied as a laboratory research material. It is not intended for human consumption, self-administration, diagnostic procedures or therapeutic use. Statements about DSIP research refer to experimental scientific trials of literature and are not meant to be read as clinical benefits or advice. The material should only be used in a scientifically controlled environment and in compliance with scientific procedures applicable to the laboratory.
